Denmark Neurology Devices Market Analysis Report 2022 to 2030

Denmark Neurology Devices Market Analysis

$ 3999

The Denmark Neurology Devices Market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Growing demand for neurology devices, technological advancements, and strategic partnerships are a few of the major market growth drivers for manufacturers in the Danish neurology devices market. The market is segmented by product type and by the end user. Some key players in this market include Neuromics, Medidyne, Medtronic, Johnson and Johnson, Boston Scientific and GE Healthcare.

ID: IN10DKMD012 CATEGORY: Medical Devices GEOGRAPHY: Denmark AUTHOR: Jigyasu Bhandari

Buy Now

Denmark Neurology Devices Market Executive Analysis

The Denmark neurology devices market is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period. For the past ten years, Denmark's health spending has stayed marginally higher than the European Union (EU) average. Between 2015 and 2019, health spending in Denmark increased at a real-term average rate of 2% per year, which is a bit slower than the European Union (EU) average. In 2019, close to 70% of adults in Denmark reported being in excellent health, which is similar to the EU average. Those with higher wages, like in other nations, are more likely to report being in good health: Compared to 62% of individuals in the lowest income quintile, 81% of Danish adults in the top income quintile reported being in good health. This income disparity was comparable to the average for the EU. In Denmark, 10.2% of GDP is spent on healthcare, which is more than the average for the Organization for Economic Co-operation and Development (OECD) countries. Typically, healthcare services are free at the point of use; roughly 84% of healthcare spending is public funding, while 16% is mostly paid by patient co-payments.

Denmark has a relatively high level of equity and well-being. With only 5.8 million people, it has a relatively high level of social equality and health equity in comparison to the rest of Europe. Compared to other nations, Denmark consistently outperforms them in terms of indicators of health, happiness, and employment standards. The Alzheimer's Association reports that 89,000 people in Denmark would have had dementia by the year 2020, and this number will likely increase as the population ages. There are about 10,000 persons in Denmark who have Parkinson's disease, according to the Danish Parkinson's Disease Association. Over 12,500 people in Denmark have Multiple sclerosis (MS), with the prevalence being higher in the country's northern regions, according to the Multiple Sclerosis Association of Denmark. There are about 400 people in Denmark who have motor neuron disease, according to the Danish Motor Neuron Disease Society.

Market Dynamics

Market Growth Drivers

Denmark's neurology devices market is expected to grow, which will likely result in a rise in manufacturers' revenues. Growing demand for neurology devices, technological advancements, and strategic partnerships are a few of the major market growth drivers for manufacturers in the Danish neurology devices market. There is a rising need for neurology devices for diagnosis and treatment as the prevalence of neurological disorders in Denmark keeps rising. Manufacturers now have the chance to create cutting-edge devices that will satisfy the demands of patients and healthcare professionals in the healthcare market. The market for neurology devices is expanding as a result of developments such as innovative implanted devices, better imaging technologies, and brain-computer interfaces. Manufacturers who make investments in R&D to create items with cutting-edge innovation are likely to see growth.

Market Restraints

Manufacturers of neurology devices may find it difficult to expand their markets in Denmark due to reimbursement policies and procedures. The Denmark regulatory environment might be difficult for companies that make neurological devices. The ability of some manufacturers to enter the market may be constrained by the lengthy and expensive process of obtaining regulatory approval for new devices.

Competitive Landscape

Key Players

Sysmex Nordic (DK)
Neuromics (DK)
Medidyne (DK)
GE Healthcare
Boston Scientific
Stryker
Johnson and Johnson
Medtronic

Recent Notable Deals

2022: The Danish business Neuromics, which specializes in the research and manufacture of neurology devices, has been bought by the Swedish medical device manufacturer Doro AB. The acquisition increased Doro's product line and strengthened its position in the market for neurology devices.

Healthcare Policies and Regulatory Landscape

The usage and marketing of neurological devices are governed by norms and regulations in Denmark's well-developed healthcare system. The Danish Medicines Agency (DMA), which is responsible for ensuring the efficacy, quality, and safety of neurology devices sold in Denmark, is in charge of overseeing the regulatory environment in Denmark. In the European Union, including Denmark, the sale and use of neurology devices are regulated by the Medical Device Regulation (MDR). Stricter guidelines for certification, labeling, and clinical evaluation of medical devices, including those used in neurology, were introduced by the MDR and took effect in May 2021. Danish Medical Device Regulations (DMR) have released standards for the certification and sale of neurology devices in Denmark. These regulations address issues like the classification of neurology devices, the registration procedure for producers, and post-market surveillance obligations.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.